These innovative therapies, including copyright , belong to a group of drugs called GLP-1 receptor agonists . Originally approved for controlling high blood sugar, they function by encouraging the organism to release sufficient insulin and curbing excessive sugar levels. Furthermore , their capacity to support slimming has resulted to significant a